Back to Search Start Over

Nanoformulations of curcumin: an emerging paradigm for improved remedial application.

Authors :
Gera M
Sharma N
Ghosh M
Huynh DL
Lee SJ
Min T
Kwon T
Jeong DK
Source :
Oncotarget [Oncotarget] 2017 Jul 11; Vol. 8 (39), pp. 66680-66698. Date of Electronic Publication: 2017 Jul 11 (Print Publication: 2017).
Publication Year :
2017

Abstract

Curcumin is a natural polyphenol and essential curcuminoid derived from the rhizome of the medicinal plant Curcuma longa ( L .) is universally acknowledged as " Wonder drug of life ". It is a vital consumable and restorative herb, commonly keened for several ailments such as cancer, arthritis, pain, bruises, gastrointestinal quandaries, swelling and much more. Despite its enormous curative potential, the poor aqueous solubility and consequently, minimal systemic bioavailability with rapid degradation are some of the major factors which restrict the utilization of curcumin at medical perspective. However, to improve its clinically relevant parameters, nanoformulation of curcumin is emerging as a novel substitute for their superior therapeutic modality. It enhances its aqueous solubility and targeted delivery to the tissue of interest that prompts to enhance the bioavailability, better drug conveyance, and more expeditious treatment. Subsequent investigations are endeavored to enhance the bio-distribution of native curcumin by modifying with felicitous nano-carriers for encapsulation. In this review, we specifically focus on the recent nanotechnology based implementations applied for overcoming the innate constraints of native curcumin and additionally the associated challenges which restrict its potential therapeutic applications both in vivo and in-vitro studies, as well as their detailed mechanism of action, have additionally been discussed.<br />Competing Interests: CONFLICTS OF INTEREST The authors declare no conflicts of interests.

Details

Language :
English
ISSN :
1949-2553
Volume :
8
Issue :
39
Database :
MEDLINE
Journal :
Oncotarget
Publication Type :
Academic Journal
Accession number :
29029547
Full Text :
https://doi.org/10.18632/oncotarget.19164